Emmanuel Gavaudan
@Boussard & Gavaudan Investment Management Llp
Latest period2024 - Q3ReportedManaged Assets$1.1BTotal holdings75
Assets growth rate75.06%Assets growth rate (2-Q avg)32.74%Continuous growth in asset value1 quarters
Portfolio positions
This chart displays the top 10 holdings in Boussard & Gavaudan Investment Management Llp's 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 75 positions.
Assets under management
The assets under management (AUM) of Boussard & Gavaudan Investment Management Llp over the past 10 years (40 quarters) show continuous growth in total asset value over the last 1 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 1.1B in assets, with a quarterly growth rate of 75.06% and a 2-quarter average growth rate of 32.74%. The portfolio is managed by Emmanuel Gavaudan, and others.
Portfolio holdings
Investment | Portfolio % | Reported Value | Recent Activity |
---|---|---|---|
5540⤦Macom Tech Solutions Hldgs I
| 0.77% | $8.456M 6,000 shares@ $1409.34 avg price | Decreased -7.86% |
SQSPSquarespace Inc
| 0.76% | $8.296M 178,803 shares@ $46.4 avg price | Increased 72.12% |
3932⤦Green Plains Inc
| 0.72% | $7.815M 9,000 shares@ $868.29 avg price | |
ANSCAgriculture & Nat Sol Acq Co
| 0.66% | $7.245M 700,000 shares@ $10.35 avg price | |
LBRDKLiberty Broadband Corp
| 0.65% | $7.059M 90,519 shares@ $77.98 avg price | Decreased -51.74% |
6093⤦Mongodb Inc
| 0.63% | $6.822M 5,000 shares@ $1364.4 avg price | New Position |
7473⤦Q2 Hldgs Inc
| 0.6% | $6.545M 6,000 shares@ $1090.77 avg price | New Position |
1945⤦Collegium Pharmaceutical Inc
| 0.6% | $6.496M 5,120 shares@ $1268.71 avg price | Decreased -28.08% |
6866⤦Ormat Technologies Inc
| 0.58% | $6.28M 6,000 shares@ $1046.63 avg price | |
8036⤦Sarepta Therapeutics Inc
| 0.58% | $6.276M 5,500 shares@ $1141.15 avg price | New Position |